Bellicum Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
35
- Latest Deal Type
-
Liquidation
Bellicum Pharmaceuticals General Information
Description
Developer of cellular immunotherapy technologies designed for controlled activation and safety management of engineered immune cells in oncology treatment. The company's platform incorporated proprietary molecular switches, inducible safety mechanisms, gene-modified T-cell engineering approaches, preclinical and clinical development programs, and intellectual property supporting regulated activation or elimination of therapeutic cells.
Contact Information
Website
www.bellicum.comCorporate Office
- 3730 Kirby Drive
- Suite 1200
- Houston, TX 77098
- United States
Corporate Office
- 3730 Kirby Drive
- Suite 1200
- Houston, TX 77098
- United States
Bellicum Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Bankruptcy: Liquidation | 20-Feb-2024 | Completed | Bankruptcy: Liquidation | |||
| 12. PIPE | 06-Dec-2021 | Completed | Generating Revenue | |||
| 11. Debt - PPP | 30-Apr-2020 | Completed | Generating Revenue | |||
| 10. 2PO | 21-Aug-2019 | Completed | Generating Revenue | |||
| 9. Grant | 16-Nov-2016 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Open Market | 01-Apr-2016 | Completed | Generating Revenue | |||
| 7. PIPE | 04-Jan-2016 | Completed | Generating Revenue | |||
| 6. IPO | 18-Dec-2014 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 02-Sep-2014 | $55M | $100M | Completed | Startup | |
| 4. Later Stage VC (Series B) | 07-Jan-2014 | $17.7M | $45.3M | Completed | Startup |
Bellicum Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,600,000 | $0.010000 | $3 | $3 | 1x | $3 | 10.43% |
Bellicum Pharmaceuticals Comparisons
Industry
Financing
Details
Bellicum Pharmaceuticals Competitors (78)
One of Bellicum Pharmaceuticals’s 78 competitors is Mustang Bio, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mustang Bio | Formerly VC-backed | Waltham, MA | ||||
| Macrogenics | Formerly VC-backed | Rockville, MD | ||||
| Celldex | Formerly VC-backed | Hampton, NJ | ||||
| iOmx Therapeutics | Venture Capital-Backed | Munich, Germany | ||||
| TME Pharma | Formerly VC-backed | Berlin, Germany |
Bellicum Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bellicum Pharmaceuticals Patents
Bellicum Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020327994-A1 | Improved formulations for immune cells | Inactive | 12-Aug-2019 | ||
| CA-3147289-A1 | Improved formulations for immune cells | Pending | 12-Aug-2019 | ||
| EP-4013513-A1 | Improved formulations for immune cells | Inactive | 12-Aug-2019 | ||
| WO-2021030482-A1 | Improved formulations for immune cells | Inactive | 12-Aug-2019 | ||
| CA-3122421-A1 | Psca car-t cells | Pending | 13-Dec-2018 | C07K14/7051 |
Bellicum Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bellicum Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Bellicum Pharmaceuticals FAQs
-
When was Bellicum Pharmaceuticals founded?
Bellicum Pharmaceuticals was founded in 2004.
-
Where is Bellicum Pharmaceuticals headquartered?
Bellicum Pharmaceuticals is headquartered in Houston, TX.
-
What is the size of Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals has 35 total employees.
-
What industry is Bellicum Pharmaceuticals in?
Bellicum Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Bellicum Pharmaceuticals a private or public company?
Bellicum Pharmaceuticals is a Private company.
-
What is Bellicum Pharmaceuticals’s current revenue?
The current revenue for Bellicum Pharmaceuticals is .
-
How much funding has Bellicum Pharmaceuticals raised over time?
Bellicum Pharmaceuticals has raised $275M.
-
Who are Bellicum Pharmaceuticals’s competitors?
Mustang Bio, Macrogenics, Celldex, iOmx Therapeutics, and TME Pharma are some of the 78 competitors of Bellicum Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
